-
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
ソース: Buzz FX / 12 1 2025 01:40:16 America/Chicago
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 12, 2025 Share Link copied to clipboard. MoonLake Immunotherapeutics ( NASDAQ:MLTX - Get Free Report
Read more...